Correlation Between Bristol-Myers Squibb and Hypercharge Networks

Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Hypercharge Networks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Hypercharge Networks into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Hypercharge Networks Corp, you can compare the effects of market volatilities on Bristol-Myers Squibb and Hypercharge Networks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Hypercharge Networks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Hypercharge Networks.

Diversification Opportunities for Bristol-Myers Squibb and Hypercharge Networks

-0.49

Correlation Coefficient

Bristol-Myers Squibb  Hypercharge Networks

Very good diversification

The 3 months correlation between Bristol-Myers and Hypercharge is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Hypercharge Networks Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hypercharge Networks Corp and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Hypercharge Networks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hypercharge Networks Corp has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Hypercharge Networks go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Hypercharge Networks

Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Hypercharge Networks. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 2.35 times less risky than Hypercharge Networks. The pink sheet trades about -0.05 of its potential returns per unit of risk. The Hypercharge Networks Corp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  5.00  in Hypercharge Networks Corp on December 2, 2024 and sell it today you would lose (0.70) from holding Hypercharge Networks Corp or give up 14.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	40.98%
Values	Daily Returns

Bristol Myers Squibb  vs.  Hypercharge Networks Corp

Bristol Myers Squibb

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest fragile performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Hypercharge Networks Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Hypercharge Networks Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, Hypercharge Networks may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Bristol-Myers Squibb and Hypercharge Networks

The main advantage of trading using opposite Bristol-Myers Squibb and Hypercharge Networks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Hypercharge Networks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hypercharge Networks will offset losses from the drop in Hypercharge Networks' long position.

The idea behind Bristol Myers Squibb and Hypercharge Networks Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.